India’s one of the leading manufacturer of medicines is ought to be a major part in the race of covid-19 vaccine all over the world. the first potential covid-19 vaccine has been given DCGI ( Drug Controller General of India) approval for the human trials which is planned to be held in the month of July across the nation.

This covaxin has been developed ny Hyderabad-based bharat biotech , kin association with ICMR ( Indian Council fro Medical Research). this is an inactivated vaccine, made from a strain of the infectious SARS-CoV-2 virus, that has shown positive results in pre clinical studies. since covid-19 has never been identified in humans before, it is difficult to find the vaccine which takes efforts all over the world.

The number of drugs manufactured from other countries were also in process , in which last week WHO (World Health Organization) said Astrazeneca’s vaccine was probably the leading candidate in this race. the british company has already begun the human trials of drugs developed by researchers at University of Oxford.